跳至主要内容
临床试验/NCT02030236
NCT02030236Unknown不适用

CAERvest® - A Novel Endothermic Hypothermic Device for Core Body Cooling. Safety and Efficacy Testing.

Bodychillz Ltd1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2014年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
1
主要终点
Reduction in core body temperature by 1 degree Centigrade.

研究概览

简要总结

Cooling the whole body to 32-34 degrees Centigrade from the normal of around 37 degrees Centigrade for 24 hours has been shown to be an effective way of reducing damage to brain function after return of spontaneous circulation when someone has been resuscitated from cardiac arrest. Cardiac arrest is a form of heart attack where the heart stops pumping.

The device is a prototype cooling vest. The investigators anticipate that this will be useful in ambulances, helicopters and emergency departments where there is a need for a portable, safe, easy-to-use, inexpensive, external, effective, readily-controlled and single-patient use device able to reduce body temperature by at least 1 degree Centigrade an hour to initiate cooling. What the investigators are doing in these trials is to demonstrate that the investigators can cool people and to get the best design possible for patient use. That means some of the initial prototypes will not resemble what we expect the eventual device to look like. The investigators will be undertaking the initial trials on 30 normal volunteers.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Human volunteers aged over
  • •The upper age limit, as is standard for risk mitigation in such studies, is
  • •The volunteer must have capacity to understand the trial and give informed consent to participate. If the volunteer's first language is not English we will make use of Sussex Interpreting Services, a professional interpreting service.

排除标准

  • •Pregnancy. Any disclosed medical condition. Any medical condition detected on examination. Core temperature outside stated parameters.
  • •We will ask the volunteer to confirm that they are otherwise healthy, taking no regular medication (except the oral contraceptive pill), are not using recreational drugs and have no significant past medical history, in particular cardiovascular disease of any sort, thyroid disease, diabetes mellitus or other metabolic disease.

研究组 & 干预措施

Cooling

Experimental

干预措施: Cooling (Device)

结局指标

主要结局

Reduction in core body temperature by 1 degree Centigrade.

时间窗: 1 hour.

The cooling properties of the vest are under investigation, and this reduction is the primary outcome measure.

次要结局

  • Skin condition.(3 days.)
  • Sepsis.(3 days.)
  • ECG abnormalities.(3 hours.)

研究者

发起方
Bodychillz Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验